term	subset	value	exact_matches	conceptual_matches	total_matches	
:customer	Segmentation		14	0	14	
DOP	Segmentation		3	93	96	
net	Segmentation		3	18	21	
IDN	Segmentation		8	100	108	
AIM	Segmentation		4	12	16	
PBM	Segmentation		4	122	126	
budget	Segmentation		4	162	166	
medical policy	Segmentation		10	161	171	
contract	Segmentation		12	83	95	
BCBS	Segmentation		7	81	88	
discount	Segmentation		7	98	105	
HEOR	Segmentation		16	20	36	
policy	Segmentation		18	128	146	
pharmacy	Segmentation		29	48	77	
health	Segmentation		25	0	25	
feedback	Segmentation		10	8	18	
class	Segmentation		21	0	21	
models	Segmentation		12	4	16	
product	Segmentation		37	20	57	
Director	Segmentation		41	32	73	
large academic center stated	Segmentation	  Access Influencers	25	347	372	
NCCN institution	Segmentation	  Access Influencers	16	109	125	
NTL	Segmentation	  Access Influencers	311	710	1021	
context of an online lecture	Segmentation	  Clinical Practice Influencers	7	659	666	
NCCN 2016 Webex Congress Series	Segmentation	  Clinical Practice Influencers	7	657	664	
comers	Segmentation	  Clinical Practice Influencers	20	0	20	
member	Segmentation	  Clinical Practice Influencers	37	111	148	
podium	Segmentation	  Clinical Practice Influencers	46	474	520	
NCCN	Segmentation	  Clinical Practice Influencers	229	106	335	
TLs	Segmentation	  Clinical Practice Influencers	98	6	104	
panelist	Segmentation	  Clinical Practice Influencers	134	164	298	
national	Segmentation	  Clinical Practice Influencers	183	979	1162	
NTL	Segmentation	  Clinical Practice Influencers	311	710	1021	
IO	Segmentation	  Clinical Practice Influencers	242	52	294	
cost	Segmentation	  Clinical Practice Influencers	103	168	271	
1L	Segmentation	  Clinical Practice Influencers	288	292	580	
Executive Director	Segmentation	  Economic/Value Influencers	4	56	60	
NAI	Segmentation	  Economic/Value Influencers	7	282	289	
proactive meeting to discuss CM-026	Segmentation	  Economic/Value Influencers	7	257	264	
member	Segmentation	  Economic/Value Influencers	37	111	148	
CM-026	Segmentation	  Economic/Value Influencers	52	177	229	
pathway	Segmentation	  Economic/Value Influencers	56	48	104	
cost	Segmentation	  Economic/Value Influencers	103	168	271	
NTL in the Boston area mentioned	Segmentation	  High Disease Burden Clinicians	9	137	146	
territory	Segmentation	  High Disease Burden Clinicians	35	349	384	
regional TL shared	Segmentation	  High Disease Burden Clinicians	18	18	36	
large academic center stated	Segmentation	  High Disease Burden Clinicians	25	347	372	
shared the following unsolicited insights	Segmentation	  High Disease Burden Clinicians	26	724	750	
Ipi+Nivo	Segmentation	  High Disease Burden Clinicians	45	338	383	
international GI conference	Segmentation	  Scientific Experts	17	43	60	
NTL said	Segmentation	  Scientific Experts	24	14	38	
large academic center stated	Segmentation	  Scientific Experts	25	347	372	
National TL	Segmentation	  Scientific Experts	51	544	595	
NTL	Segmentation	  Scientific Experts	311	710	1021	
said	Segmentation	  Scientific Experts	479	0	479	
NCCN institution	Segmentation	 Access Decision Makers	16	109	125	
Path TL	Segmentation	 Access Decision Makers	18	230	248	
large academic center stated	Segmentation	 Access Decision Makers	25	347	372	
NTL	Segmentation	 Access Decision Makers	311	710	1021	
AI stated	Segmentation	 Access Influencers	24	171	195	
provided the following unsolicited insights	Segmentation	 Access Influencers	45	146	191	
shared the following unsolicited insights	Segmentation	 Access Influencers	26	724	750	
NCCN panelist for NSCLC	Segmentation	 Access Influencers	11	482	493	
RAI	Segmentation	 Access Influencers	15	701	716	
Met with a national/regional lung	Segmentation	 Access Influencers	10	211	221	
AI/TL post-ESMO	Segmentation	 Access Influencers	9	660	669	
AI/TL	Segmentation	 Access Influencers	27	661	688	
advisor	Segmentation	 Access Influencers	27	231	258	
NSCLC NCCN panelist	Segmentation	 Access Influencers	17	665	682	
AI	Segmentation	 Access Influencers	121	70	191	
context of an online lecture	Segmentation	 Access Influencers	7	659	666	
NAI	Segmentation	 Access Influencers	7	282	289	
NCCN 2016 Webex Congress Series	Segmentation	 Access Influencers	7	657	664	
proactive meeting to discuss CM-026	Segmentation	 Access Influencers	7	257	264	
southeast region	Segmentation	 Access Influencers	7	169	176	
Met with a national	Segmentation	 Access Influencers	25	644	669	
panelist	Segmentation	 Access Influencers	134	164	298	
Met with a regional	Segmentation	 Access Influencers	21	174	195	
NCCN center in the midwest stated	Segmentation	 Access Influencers	12	299	311	
international GI conference	Segmentation	 Clinical Practice Influencers	17	43	60	
ie	Segmentation	 Clinical Practice Influencers	52	0	52	
RTL	Segmentation	 Clinical Practice Influencers	690	801	1491	
billing	Segmentation	 Economic/Value Influencers	9	11	20	
Local lung TL commented	Segmentation	 High Disease Burden Clinicians	14	0	14	
Local TL	Segmentation	 High Disease Burden Clinicians	52	1414	1466	
LTL	Segmentation	 High Disease Burden Clinicians	79	800	879	
Community TL	Segmentation	 High Disease Burden Clinicians	73	820	893	
community oncologist	Segmentation	 High Disease Burden Clinicians	57	939	996	
HCP	Segmentation	 High Disease Burden Clinicians	115	124	239	
Local	Segmentation	 High Disease Burden Clinicians	184	1056	1240	
IMAR management	Segmentation	 N/A	11	373	384	
dinner	Segmentation	 N/A	11	199	210	
IMAR	Segmentation	 N/A	27	141	168	
administration	Segmentation	 N/A	15	0	15	
nurse	Segmentation	 N/A	41	193	234	
staff	Segmentation	 N/A	27	72	99	
algorithms	Segmentation	 N/A	32	234	266	
large community practice	Segmentation	 N/A	42	1884	1926	
IMARs	Segmentation	 N/A	34	278	312	
indicated	Segmentation	 N/A	79	459	538	
noted	Segmentation	 N/A	144	0	144	
practice	Segmentation	 N/A	258	718	976	
NW territory	Segmentation	 Scientific Experts	14	1448	1462	
Dako	Segmentation	 Scientific Experts	17	124	141	
Lung RTL shared	Segmentation	 Scientific Experts	15	59	74	
SP142	Segmentation	 Scientific Experts	17	146	163	
pathologist	Segmentation	 Scientific Experts	45	211	256	
PD-1	Segmentation	 Scientific Experts	133	215	348	
sent	Segmentation	 Scientific Experts	64	529	593	
PD-L1 testing	Segmentation	 Scientific Experts	123	444	567	
cases	Segmentation	 Scientific Experts	117	0	117	
pts	Segmentation	 Scientific Experts	164	1624	1788	
NTL	Segmentation	 Scientific Experts	311	710	1021	
TL	Segmentation	 Scientific Experts	1157	51	1208	
2L	Territory		215	404	619	
lung TL said	Territory	  CLEVELAND	16	1110	1126	
atezi	Territory	  CLEVELAND	5	27	32	
Regional lung TL told	Territory	  CLEVELAND	21	2	23	
Fall ECOG	Territory	  CLEVELAND	4	148	152	
voiced his opinion	Territory	  CLEVELAND	7	16	23	
Local lung TL commented	Territory	  CLEVELAND	14	0	14	
isn	Territory	  CLEVELAND	11	106	117	
GR	Territory	  CLEVELAND	5	0	5	
second	Territory	  CLEVELAND	5	0	5	
H&N TL	Territory	  CLEVELAND	20	432	452	
sutent	Territory	  CLEVELAND	8	3	11	
TL told	Territory	  CLEVELAND	65	938	1003	
Local	Territory	  CLEVELAND	184	1056	1240	
t	Territory	  CLEVELAND	117	0	117	
doesn	Territory	  CLEVELAND	36	94	130	
TL said	Territory	  CLEVELAND	86	62	148	
said	Territory	  CLEVELAND	479	0	479	
line	Territory	  CLEVELAND	345	108	453	
told	Territory	  CLEVELAND	136	65	201	
national	Territory	  CLEVELAND	183	979	1162	
HCP	Territory	  FL PANHANDLE	115	124	239	
PD-L1 testing	Territory	  ACTICES & IMPLEMENTATION	123	444	567	
NW territory	Territory	  AK	14	1448	1462	
sky-rocketed	Territory	  AK	3	577	580	
NeoGenomics	Territory	  AK	8	554	562	
laboratory	Territory	  AK	7	1271	1278	
clone	Territory	  AK	5	149	154	
diagnostics	Territory	  AK	8	1288	1296	
medical director	Territory	  AK	8	365	373	
healthcare	Territory	  AK	6	688	694	
Ventana platform	Territory	  AK	7	145	152	
reflex testing	Territory	  AK	11	91	102	
medical oncologists	Territory	  AK	23	176	199	
platform	Territory	  AK	18	149	167	
IHC	Territory	  AK	25	536	561	
insights	Territory	  AK	137	0	137	
molecular	Territory	  AK	17	42	59	
SP142	Territory	  AK	17	146	163	
pathologist	Territory	  AK	45	211	256	
network	Territory	  AK	18	441	459	
pathology	Territory	  AK	19	213	232	
gained	Territory	  AK	19	86	105	
Pediatric	Territory	  AL	11	367	378	
regional TL shared	Territory	  AL	18	18	36	
achieved a CR	Territory	  AL	18	356	374	
offered	Territory	  AL	88	0	88	
TL shared	Territory	  AL	119	1081	1200	
academic center	Territory	  AL	103	319	422	
Regional TL	Territory	  AL	100	1088	1188	
nivolumab	Territory	  AL	335	5	340	
said	Territory	  AL	479	0	479	
Biodesix	Territory	  APE/COMPETITOR INFORMATION	4	34	38	
cabozatanib	Territory	  AR	13	190	203	
trx	Territory	  AR	10	0	10	
pace	Territory	  AR	8	208	216	
aPD1	Territory	  AR	7	635	642	
Pan-tumor	Territory	  AR	18	464	482	
Pediatric	Territory	  AR	11	367	378	
ie	Territory	  AR	52	0	52	
modest	Territory	  AR	9	142	151	
2L+	Territory	  AR	12	334	346	
GU RTL stated	Territory	  AR	13	433	446	
Pan	Territory	  AR	10	0	10	
IL-2	Territory	  AR	16	48	64	
not test for PDL1	Territory	  AR	14	651	665	
axitinib	Territory	  AR	14	482	496	
HN	Territory	  AR	21	1	22	
GU	Territory	  AR	84	815	899	
nearly	Territory	  AR	23	0	23	
completely	Territory	  AR	26	3	29	
testing for PDL1	Territory	  AR	39	575	614	
Ipi+Nivo	Territory	  AR	45	338	383	
PTCL	Territory	  ATION/ ISRS	3	139	142	
Numerous TLs	Territory	  AZ	6	253	259	
tone	Territory	  AZ	4	0	4	
restriction	Territory	  AZ	6	16	22	
AE profile	Territory	  AZ	14	338	352	
comers	Territory	  AZ	20	0	20	
q3wk	Territory	  AZ	14	425	439	
TLs	Territory	  AZ	98	6	104	
established	Territory	  AZ	17	0	17	
IO-IO	Territory	  AZ	21	757	778	
highly	Territory	  AZ	30	34	64	
key	Territory	  AZ	37	0	37	
PDL1 status	Territory	  AZ	39	874	913	
SOC	Territory	  AZ	69	492	561	
specifically	Territory	  AZ	50	48	98	
regards	Territory	  AZ	112	0	112	
increase	Territory	  AZ	113	36	149	
indication	Territory	  AZ	99	0	99	
population	Territory	  AZ	222	248	470	
IO	Territory	  AZ	242	52	294	
1L	Territory	  AZ	288	292	580	
Numerous TLs	Territory	  CO	6	253	259	
tone	Territory	  CO	4	0	4	
AE profile	Territory	  CO	14	338	352	
like to see a trial	Territory	  CO	15	14	29	
comers	Territory	  CO	20	0	20	
TLs	Territory	  CO	98	6	104	
highly	Territory	  CO	30	34	64	
regards	Territory	  CO	112	0	112	
IO	Territory	  CO	242	52	294	
Path TL	Territory	  CT	18	230	248	
southeast region	Territory	  CT	7	169	176	
cHD	Territory	  CT	6	318	324	
gathered the following unsolicited	Territory	  CT	6	175	181	
Ritchie	Territory	  CT	6	170	176	
Path	Territory	  CT	19	0	19	
NCI-designated	Territory	  CT	8	157	165	
Joseph	Territory	  CT	7	170	177	
1st line NSCLC	Territory	  CT	17	26	43	
evolving	Territory	  CT	10	77	87	
reflex testing	Territory	  CT	11	91	102	
comparable	Territory	  CT	13	498	511	
score	Territory	  CT	21	156	177	
Boston	Territory	  CT	40	82	122	
pathologist	Territory	  CT	45	211	256	
22C3	Territory	  CT	49	112	161	
order	Territory	  CT	55	550	605	
1st line	Territory	  CT	69	712	781	
pts	Territory	  CT	164	1624	1788	
PD-L1	Territory	  CT	306	375	681	
corticosteroids	Territory	  DE	17	260	277	
thought leader	Territory	  DE	25	22	47	
National TL	Territory	  DE	51	544	595	
competitor	Territory	  DE	33	0	33	
major	Territory	  DE	90	483	573	
PDL-1	Territory	  DE	50	881	931	
Regional TL	Territory	  DE	100	1088	1188	
reported	Territory	  DE	182	10	192	
auto	Territory	  FL	15	204	219	
pt	Territory	  FL	67	23	90	
reported	Territory	  FL	182	10	192	
regional TL shared	Territory	  GA	18	18	36	
anti-PD1	Territory	  GA	38	55	93	
TL told	Territory	  GA	65	938	1003	
TL shared	Territory	  GA	119	1081	1200	
commented	Territory	  GA	295	327	622	
cytology	Territory	  HI	4	159	163	
volume	Territory	  HI	31	9	40	
in-house	Territory	  HI	25	127	152	
score	Territory	  HI	21	156	177	
requests	Territory	  HI	61	545	606	
RTL from a major academic institution	Territory	  IA	20	232	252	
community institution	Territory	  IA	31	221	252	
026 Top 300	Territory	  IA	7	245	252	
large community institution	Territory	  IA	13	1371	1384	
NOT Top 300	Territory	  IA	4	248	252	
academic institution mentioned	Territory	  IA	14	47	61	
single-agent	Territory	  IA	5	0	5	
KEYNOTE-024	Territory	  IA	19	76	95	
opted	Territory	  IA	6	246	252	
CheckMate 227	Territory	  IA	8	8	16	
progressive	Territory	  IA	7	245	252	
second-line	Territory	  IA	17	63	80	
eager	Territory	  IA	10	7	17	
first-line	Territory	  IA	26	54	80	
major academic institution	Territory	  IA	34	225	259	
top	Territory	  IA	23	0	23	
RTL mentioned	Territory	  IA	27	0	27	
Checkmate	Territory	  IA	87	792	879	
PD-L1 expression	Territory	  IA	72	703	775	
I-O	Territory	  IA	60	0	60	
NW territory	Territory	  ID	14	1448	1462	
ASCO'16	Territory	  ID	5	394	399	
NeoGenomics	Territory	  ID	8	554	562	
laboratory	Territory	  ID	7	1271	1278	
like to see a trial	Territory	  ID	15	14	29	
Academic TL stated	Territory	  ID	16	162	178	
Ipi+Nivo	Territory	  ID	45	338	383	
medical oncologists	Territory	  ID	23	176	199	
insights	Territory	  ID	137	0	137	
TL said	Territory	  ID	86	62	148	
pathologist	Territory	  ID	45	211	256	
TL	Territory	  ID	1157	51	1208	
large academic center stated	Territory	  IN	25	347	372	
Lung RTL shared	Territory	  IN	15	59	74	
midwest	Territory	  IN	42	124	166	
mostly	Territory	  IN	34	0	34	
cut-off	Territory	  IN	26	695	721	
submitted	Territory	  IN	21	96	117	
PDL-1	Territory	  IN	50	881	931	
second line	Territory	  IN	78	247	325	
pts	Territory	  IN	164	1624	1788	
line	Territory	  IN	345	108	453	
added	Territory	  IN	148	0	148	
NTL	Territory	  IN	311	710	1021	
shared	Territory	  IN	507	1	508	
CLL	Territory	  KS	5	98	103	
like to see a trial	Territory	  KS	15	14	29	
GVHD	Territory	  KS	21	118	139	
TL commented	Territory	  KY	83	892	975	
presenter	Territory	  KY	14	1	15	
Local TL	Territory	  KY	52	1414	1466	
I/O	Territory	  KY	36	184	220	
Academic TL	Territory	  KY	65	167	232	
commented	Territory	  KY	295	327	622	
Pediatric Oncology/ Hematology	Territory	  LA	4	319	323	
Pediatric	Territory	  LA	11	367	378	
Brentuximab vedotin	Territory	  LA	11	135	146	
described	Territory	  LA	44	0	44	
academic center	Territory	  LA	103	319	422	
lymphoma	Territory	  LA	73	12	85	
transplant	Territory	  LA	92	193	285	
cHL	Territory	  LA	116	190	306	
PR Hem Onc Symposium	Territory	  LANDSCAPE	5	142	147	
Path TL	Territory	  MA	18	230	248	
NTL in the Boston area mentioned	Territory	  MA	9	137	146	
Boston area	Territory	  MA	19	27	46	
Path	Territory	  MA	19	0	19	
IVD	Territory	  MA	6	146	152	
score	Territory	  MA	21	156	177	
pathologist	Territory	  MA	45	211	256	
Boston	Territory	  MA	40	82	122	
22C3	Territory	  MA	49	112	161	
BV	Territory	  MA	33	158	191	
stop	Territory	  MA	67	137	204	
mentioned	Territory	  MA	289	130	419	
reported	Territory	  MA	182	10	192	
standardized	Territory	  MD	8	132	140	
Path TL	Territory	  ME	18	230	248	
Boston area	Territory	  ME	19	27	46	
NTL in the Boston area mentioned	Territory	  ME	9	137	146	
Path	Territory	  ME	19	0	19	
Boston	Territory	  ME	40	82	122	
rounds	Territory	  ME	8	5	13	
1st line NSCLC	Territory	  ME	17	26	43	
score	Territory	  ME	21	156	177	
pathologist	Territory	  ME	45	211	256	
22C3	Territory	  ME	49	112	161	
1st line	Territory	  ME	69	712	781	
pts	Territory	  ME	164	1624	1788	
LTL	Territory	  ME	79	800	879	
PD-L1	Territory	  ME	306	375	681	
mentioned	Territory	  ME	289	130	419	
NCI	Territory	  MI	16	112	128	
hematologic malignancies	Territory	  MI	5	4	9	
PET	Territory	  MI	11	0	11	
cancer center	Territory	  MI	46	130	176	
lymphoma	Territory	  MI	73	12	85	
academic center	Territory	  MI	103	319	422	
noted	Territory	  MI	144	0	144	
RTL from a major academic institution	Territory	  MN	20	232	252	
community institution	Territory	  MN	31	221	252	
026 Top 300	Territory	  MN	7	245	252	
large community institution	Territory	  MN	13	1371	1384	
NCI	Territory	  MN	16	112	128	
NOT Top 300	Territory	  MN	4	248	252	
academic institution mentioned	Territory	  MN	14	47	61	
single-agent	Territory	  MN	5	0	5	
KEYNOTE-024	Territory	  MN	19	76	95	
CheckMate 227	Territory	  MN	8	8	16	
second-line	Territory	  MN	17	63	80	
eager	Territory	  MN	10	7	17	
first-line	Territory	  MN	26	54	80	
top	Territory	  MN	23	0	23	
major academic institution	Territory	  MN	34	225	259	
RTL mentioned	Territory	  MN	27	0	27	
Checkmate	Territory	  MN	87	792	879	
PD-L1 expression	Territory	  MN	72	703	775	
pembrolizumab	Territory	  MN	65	45	110	
RTL	Territory	  MN	690	801	1491	
cabozatanib	Territory	  MO	13	190	203	
trx	Territory	  MO	10	0	10	
pace	Territory	  MO	8	208	216	
aPD1	Territory	  MO	7	635	642	
Pan-tumor	Territory	  MO	18	464	482	
ie	Territory	  MO	52	0	52	
modest	Territory	  MO	9	142	151	
2L+	Territory	  MO	12	334	346	
IL-2	Territory	  MO	16	48	64	
GU RTL stated	Territory	  MO	13	433	446	
Pan	Territory	  MO	10	0	10	
not test for PDL1	Territory	  MO	14	651	665	
axitinib	Territory	  MO	14	482	496	
HN	Territory	  MO	21	1	22	
GU	Territory	  MO	84	815	899	
3L	Territory	  MO	19	518	537	
sunitinib	Territory	  MO	19	348	367	
nearly	Territory	  MO	23	0	23	
completely	Territory	  MO	26	3	29	
testing for PDL1	Territory	  MO	39	575	614	
Pediatric	Territory	  MS	11	367	378	
regional TL shared	Territory	  MS	18	18	36	
achieved a CR	Territory	  MS	18	356	374	
offered	Territory	  MS	88	0	88	
TL shared	Territory	  MS	119	1081	1200	
described	Territory	  MS	44	0	44	
academic center	Territory	  MS	103	319	422	
Regional TL	Territory	  MS	100	1088	1188	
nivolumab	Territory	  MS	335	5	340	
said	Territory	  MS	479	0	479	
HCP	Territory	  MSL	115	124	239	
NW territory	Territory	  MT	14	1448	1462	
ASCO'16	Territory	  MT	5	394	399	
NeoGenomics	Territory	  MT	8	554	562	
laboratory	Territory	  MT	7	1271	1278	
like to see a trial	Territory	  MT	15	14	29	
Academic TL stated	Territory	  MT	16	162	178	
Ipi+Nivo	Territory	  MT	45	338	383	
medical oncologists	Territory	  MT	23	176	199	
insights	Territory	  MT	137	0	137	
TL said	Territory	  MT	86	62	148	
pathologist	Territory	  MT	45	211	256	
TL	Territory	  MT	1157	51	1208	
tolerance	Territory	  N. FL	4	0	4	
oncology	Territory	  N. FL	97	148	245	
practice	Territory	  N. FL	258	718	976	
NW territory	Territory	  N.CA	14	1448	1462	
sky-rocketed	Territory	  N.CA	3	577	580	
NeoGenomics	Territory	  N.CA	8	554	562	
laboratory	Territory	  N.CA	7	1271	1278	
clone	Territory	  N.CA	5	149	154	
diagnostics	Territory	  N.CA	8	1288	1296	
medical director	Territory	  N.CA	8	365	373	
reflex testing	Territory	  N.CA	11	91	102	
medical oncologists	Territory	  N.CA	23	176	199	
platform	Territory	  N.CA	18	149	167	
IHC	Territory	  N.CA	25	536	561	
insights	Territory	  N.CA	137	0	137	
molecular	Territory	  N.CA	17	42	59	
SP142	Territory	  N.CA	17	146	163	
pathologist	Territory	  N.CA	45	211	256	
in-house	Territory	  N.CA	25	127	152	
22C3	Territory	  N.CA	49	112	161	
Community TL	Territory	  N.CA	73	820	893	
sent	Territory	  N.CA	64	529	593	
utilized	Territory	  N.CA	45	0	45	
NW territory	Territory	  N.NV	14	1448	1462	
sky-rocketed	Territory	  N.NV	3	577	580	
NeoGenomics	Territory	  N.NV	8	554	562	
laboratory	Territory	  N.NV	7	1271	1278	
clone	Territory	  N.NV	5	149	154	
diagnostics	Territory	  N.NV	8	1288	1296	
medical director	Territory	  N.NV	8	365	373	
healthcare	Territory	  N.NV	6	688	694	
Ventana platform	Territory	  N.NV	7	145	152	
reflex testing	Territory	  N.NV	11	91	102	
medical oncologists	Territory	  N.NV	23	176	199	
platform	Territory	  N.NV	18	149	167	
IHC	Territory	  N.NV	25	536	561	
insights	Territory	  N.NV	137	0	137	
molecular	Territory	  N.NV	17	42	59	
SP142	Territory	  N.NV	17	146	163	
pathologist	Territory	  N.NV	45	211	256	
network	Territory	  N.NV	18	441	459	
pathology	Territory	  N.NV	19	213	232	
gained	Territory	  N.NV	19	86	105	
Neuro-ONC	Territory	  NC	11	39	50	
National Thought leader	Territory	  NC	9	0	9	
respect	Territory	  NC	20	122	142	
GBM	Territory	  NC	49	79	128	
IO therapy	Territory	  NC	64	26	90	
NCI	Territory	  ND	16	112	128	
hematologic malignancies	Territory	  ND	5	4	9	
PET	Territory	  ND	11	0	11	
cancer center	Territory	  ND	46	130	176	
lymphoma	Territory	  ND	73	12	85	
academic center	Territory	  ND	103	319	422	
noted	Territory	  ND	144	0	144	
Numerous TLs	Territory	  NE	6	253	259	
tone	Territory	  NE	4	0	4	
AE profile	Territory	  NE	14	338	352	
like to see a trial	Territory	  NE	15	14	29	
comers	Territory	  NE	20	0	20	
q3wk	Territory	  NE	14	425	439	
TLs	Territory	  NE	98	6	104	
IO-IO	Territory	  NE	21	757	778	
highly	Territory	  NE	30	34	64	
regards	Territory	  NE	112	0	112	
increase	Territory	  NE	113	36	149	
Path TL	Territory	  NH	18	230	248	
Path	Territory	  NH	19	0	19	
IVD	Territory	  NH	6	146	152	
1st line NSCLC	Territory	  NH	17	26	43	
score	Territory	  NH	21	156	177	
Boston	Territory	  NH	40	82	122	
pathologist	Territory	  NH	45	211	256	
22C3	Territory	  NH	49	112	161	
1st line	Territory	  NH	69	712	781	
pts	Territory	  NH	164	1624	1788	
LTL	Territory	  NH	79	800	879	
PD-L1	Territory	  NH	306	375	681	
PD-L1 testing	Territory	  NH	123	444	567	
added	Territory	  NH	148	0	148	
southeast region	Territory	  NJ	7	169	176	
cHD	Territory	  NJ	6	318	324	
gathered the following unsolicited	Territory	  NJ	6	175	181	
Ritchie	Territory	  NJ	6	170	176	
NCI-designated	Territory	  NJ	8	157	165	
Joseph	Territory	  NJ	7	170	177	
NCCN panel member	Territory	  NJ	9	561	570	
corticosteroids	Territory	  NJ	17	260	277	
comparable	Territory	  NJ	13	498	511	
thought leader	Territory	  NJ	25	22	47	
member	Territory	  NJ	37	111	148	
National TL	Territory	  NJ	51	544	595	
patients respond	Territory	  NJ	37	22	59	
major	Territory	  NJ	90	483	573	
Regional TL	Territory	  NJ	100	1088	1188	
opinion	Territory	  NJ	72	109	181	
reported	Territory	  NJ	182	10	192	
Numerous TLs	Territory	  NM	6	253	259	
tone	Territory	  NM	4	0	4	
restriction	Territory	  NM	6	16	22	
AE profile	Territory	  NM	14	338	352	
comers	Territory	  NM	20	0	20	
q3wk	Territory	  NM	14	425	439	
TLs	Territory	  NM	98	6	104	
established	Territory	  NM	17	0	17	
IO-IO	Territory	  NM	21	757	778	
highly	Territory	  NM	30	34	64	
key	Territory	  NM	37	0	37	
SOC	Territory	  NM	69	492	561	
regards	Territory	  NM	112	0	112	
increase	Territory	  NM	113	36	149	
indication	Territory	  NM	99	0	99	
population	Territory	  NM	222	248	470	
IO	Territory	  NM	242	52	294	
q3wk	Territory	  NV	14	425	439	
myocarditis	Territory	  NV	12	62	74	
TLs have stated	Territory	  NV	21	203	224	
IO-IO	Territory	  NV	21	757	778	
PDL-1	Territory	  NV	50	881	931	
Community TL	Territory	  NV	73	820	893	
large academic center stated	Territory	  OH	25	347	372	
midwest	Territory	  OH	42	124	166	
TL commented	Territory	  OH	83	892	975	
PDL-1	Territory	  OH	50	881	931	
mostly	Territory	  OH	34	0	34	
meeting	Territory	  OH	239	35	274	
line	Territory	  OH	345	108	453	
BMS-sponsored	Territory	  OK	2	50	52	
novel	Territory	  OK	10	9	19	
uveal	Territory	  OM	5	424	429	
years old	Territory	  OM	8	0	8	
objective responses	Territory	  OM	8	3	11	
BRAF/MEK	Territory	  OM	10	362	372	
BRAF	Territory	  OM	38	209	247	
regimen	Territory	  OM	243	465	708	
NW territory	Territory	  OR	14	1448	1462	
ASCO'16	Territory	  OR	5	394	399	
NeoGenomics	Territory	  OR	8	554	562	
laboratory	Territory	  OR	7	1271	1278	
Academic TL stated	Territory	  OR	16	162	178	
community hospital	Territory	  OR	19	551	570	
Ipi+Nivo	Territory	  OR	45	338	383	
medical oncologists	Territory	  OR	23	176	199	
insights	Territory	  OR	137	0	137	
IHC	Territory	  OR	25	536	561	
TL said	Territory	  OR	86	62	148	
pathologist	Territory	  OR	45	211	256	
TL	Territory	  OR	1157	51	1208	
MedOncs	Territory	  PA	4	131	135	
machines	Territory	  PA	3	147	150	
standardized	Territory	  PA	8	132	140	
complementary	Territory	  PA	4	138	142	
SP263	Territory	  PA	8	144	152	
tumor cells	Territory	  PA	22	82	104	
Dako	Territory	  PA	17	124	141	
staining	Territory	  PA	32	620	652	
22C3	Territory	  PA	49	112	161	
aware	Territory	  PA	57	0	57	
PD-L1	Territory	  PA	306	375	681	
Path TL	Territory	  RI	18	230	248	
Path	Territory	  RI	19	0	19	
IVD	Territory	  RI	6	146	152	
1st line NSCLC	Territory	  RI	17	26	43	
score	Territory	  RI	21	156	177	
Boston	Territory	  RI	40	82	122	
pathologist	Territory	  RI	45	211	256	
22C3	Territory	  RI	49	112	161	
1st line	Territory	  RI	69	712	781	
pts	Territory	  RI	164	1624	1788	
LTL	Territory	  RI	79	800	879	
PD-L1	Territory	  RI	306	375	681	
PD-L1 testing	Territory	  RI	123	444	567	
added	Territory	  RI	148	0	148	
cabozatanib	Territory	  S. IL	13	190	203	
trx	Territory	  S. IL	10	0	10	
pace	Territory	  S. IL	8	208	216	
aPD1	Territory	  S. IL	7	635	642	
Pan-tumor	Territory	  S. IL	18	464	482	
ie	Territory	  S. IL	52	0	52	
modest	Territory	  S. IL	9	142	151	
2L+	Territory	  S. IL	12	334	346	
GU RTL stated	Territory	  S. IL	13	433	446	
Pan	Territory	  S. IL	10	0	10	
IL-2	Territory	  S. IL	16	48	64	
not test for PDL1	Territory	  S. IL	14	651	665	
axitinib	Territory	  S. IL	14	482	496	
HN	Territory	  S. IL	21	1	22	
GU	Territory	  S. IL	84	815	899	
3L	Territory	  S. IL	19	518	537	
sunitinib	Territory	  S. IL	19	348	367	
nearly	Territory	  S. IL	23	0	23	
completely	Territory	  S. IL	26	3	29	
testing for PDL1	Territory	  S. IL	39	575	614	
HCP	Territory	  S. TN	115	124	239	
cytology	Territory	  S.CA	4	159	163	
volume	Territory	  S.CA	31	9	40	
in-house	Territory	  S.CA	25	127	152	
score	Territory	  S.CA	21	156	177	
requests	Territory	  S.CA	61	545	606	
cytology	Territory	  S.NV	4	159	163	
volume	Territory	  S.NV	31	9	40	
in-house	Territory	  S.NV	25	127	152	
score	Territory	  S.NV	21	156	177	
requests	Territory	  S.NV	61	545	606	
GYN ONC	Territory	  SC	4	69	73	
Neuro-ONC	Territory	  SC	11	39	50	
National Thought leader	Territory	  SC	9	0	9	
respect	Territory	  SC	20	122	142	
GBM	Territory	  SC	49	79	128	
IO therapy	Territory	  SC	64	26	90	
RTL from a major academic institution	Territory	  SD	20	232	252	
community institution	Territory	  SD	31	221	252	
026 Top 300	Territory	  SD	7	245	252	
large community institution	Territory	  SD	13	1371	1384	
NCI	Territory	  SD	16	112	128	
NOT Top 300	Territory	  SD	4	248	252	
academic institution mentioned	Territory	  SD	14	47	61	
single-agent	Territory	  SD	5	0	5	
KEYNOTE-024	Territory	  SD	19	76	95	
CheckMate 227	Territory	  SD	8	8	16	
second-line	Territory	  SD	17	63	80	
eager	Territory	  SD	10	7	17	
first-line	Territory	  SD	26	54	80	
top	Territory	  SD	23	0	23	
major academic institution	Territory	  SD	34	225	259	
RTL mentioned	Territory	  SD	27	0	27	
Checkmate	Territory	  SD	87	792	879	
pembrolizumab	Territory	  SD	65	45	110	
cancer center	Territory	  SD	46	130	176	
PD-L1 expression	Territory	  SD	72	703	775	
PTCL	Territory	  SRs	3	139	142	
pt	Territory	  TN	67	23	90	
large community practice	Territory	  TN	42	1884	1926	
voluntarily	Territory	  TX	7	0	7	
I-O agents	Territory	  TX	14	6	20	
H&N cancer	Territory	  TX	22	39	61	
CM-026	Territory	  TX	52	177	229	
TL shared	Territory	  TX	119	1081	1200	
feels	Territory	  TX	397	56	453	
lung TL said	Territory	  UPSTATE NY	16	1110	1126	
atezi	Territory	  UPSTATE NY	5	27	32	
Regional lung TL told	Territory	  UPSTATE NY	21	2	23	
Fall ECOG	Territory	  UPSTATE NY	4	148	152	
voiced his opinion	Territory	  UPSTATE NY	7	16	23	
Local lung TL commented	Territory	  UPSTATE NY	14	0	14	
isn	Territory	  UPSTATE NY	11	106	117	
GR	Territory	  UPSTATE NY	5	0	5	
second	Territory	  UPSTATE NY	5	0	5	
H&N TL	Territory	  UPSTATE NY	20	432	452	
sutent	Territory	  UPSTATE NY	8	3	11	
TL told	Territory	  UPSTATE NY	65	938	1003	
Local	Territory	  UPSTATE NY	184	1056	1240	
t	Territory	  UPSTATE NY	117	0	117	
doesn	Territory	  UPSTATE NY	36	94	130	
TL said	Territory	  UPSTATE NY	86	62	148	
said	Territory	  UPSTATE NY	479	0	479	
line	Territory	  UPSTATE NY	345	108	453	
told	Territory	  UPSTATE NY	136	65	201	
national	Territory	  UPSTATE NY	183	979	1162	
ONS	Territory	  UT	5	198	203	
California	Territory	  UT	8	290	298	
PD	Territory	  UT	14	3	17	
surrounding	Territory	  UT	13	0	13	
tx	Territory	  UT	24	100	124	
Onc	Territory	  UT	44	188	232	
NP	Territory	  UT	31	704	735	
symptoms	Territory	  UT	28	195	223	
nurse	Territory	  UT	41	193	234	
release	Territory	  UT	61	66	127	
large	Territory	  UT	283	242	525	
pts	Territory	  UT	164	1624	1788	
mentioned	Territory	  UT	289	130	419	
Northeast	Territory	  Upstate NY	9	121	130	
IME	Territory	  Upstate NY	3	0	3	
New England	Territory	  Upstate NY	17	970	987	
cell carcinoma	Territory	  Upstate NY	7	40	47	
NCCN institution	Territory	  Upstate NY	16	109	125	
immuno-oncology	Territory	  Upstate NY	11	54	65	
produce	Territory	  Upstate NY	11	0	11	
US	Territory	  Upstate NY	14	24	38	
thought leader	Territory	  Upstate NY	25	22	47	
Boston	Territory	  Upstate NY	40	82	122	
MD	Territory	  Upstate NY	29	71	100	
ipilimumab	Territory	  Upstate NY	22	17	39	
renal	Territory	  Upstate NY	22	26	48	
cabozantinib	Territory	  Upstate NY	27	137	164	
IO agents	Territory	  Upstate NY	45	174	219	
major	Territory	  Upstate NY	90	483	573	
advanced	Territory	  Upstate NY	36	0	36	
hospital	Territory	  Upstate NY	72	479	551	
RTL stated      Territory         VA    93      556     649
Path TL Territory         VT    18      230     248
Boston area     Territory         VT    19      27      46
NTL in the Boston area mentioned        Territory         VT    9       137     146
Path    Territory         VT    19      0       19
Boston  Territory         VT    40      82      122
rounds  Territory         VT    8       5       13
1st line NSCLC  Territory         VT    17      26      43
score   Territory         VT    21      156     177
pathologist     Territory         VT    45      211     256
22C3    Territory         VT    49 112     161  203
1st line        Territory         VT    69290   712     781
pts     Territory         VT164     162431788   17
LTL     Territory         VT    79      800     879
PD-L1   Territory         VT    306     375     681
mentioned       Territory         VT    289     130     419
NW territory    Territory         WA    14      1448    1462
sky-rocketed    Territory         WA    3  23   577     580
NeoGenomics     Territory         WA    8       554     562
laboratory      Territory         WA    7       1271    1278
clone   Territory         WA    5       149     154
diagnostics     Territory         WA    8       1288    1296
medical director        Territory         WA    8       365     373
reflex testing  Territory         WA    11      91      102
medical oncologists     Territory         WA    23      176     199
platform        Territory         WA    18      149     167
IHC     Territory         WA    25      536     561
insights        Territory         WA    137     0       137
molecular       Territory         WA    17      42      59
improved	Territory	  Upstate NY	36	0	36	
care	Territory	  Upstate NY	75	12	87	
RTL stated	Territory	  VA	93	556	649	
Path TL	Territory	  VT	18	230	248	
Boston area	Territory	  VT	19	27	46	
NTL in the Boston area mentioned	Territory	  VT	9	137	146	
Path	Territory	  VT	19	0	19	
Boston	Territory	  VT	40	82	122	
rounds	Territory	  VT	8	5	13	
1st line NSCLC	Territory	  VT	17	26	43	
score	Territory	  VT	21	156	177	
pathologist	Territory	  VT	45	211	256	
22C3	Territory	  VT	49	112	161	
1st line	Territory	  VT	69	712	781	
pts	Territory	  VT	164	1624	1788	
LTL	Territory	  VT	79	800	879	
PD-L1	Territory	  VT	306	375	681	
mentioned	Territory	  VT	289	130	419	
NW territory	Territory	  WA	14	1448	1462	
sky-rocketed	Territory	  WA	3	577	580	
NeoGenomics	Territory	  WA	8	554	562	
laboratory	Territory	  WA	7	1271	1278	
clone	Territory	  WA	5	149	154	
diagnostics	Territory	  WA	8	1288	1296	
medical director	Territory	  WA	8	365	373	
reflex testing	Territory	  WA	11	91	102	
medical oncologists	Territory	  WA	23	176	199	
platform	Territory	  WA	18	149	167	
IHC	Territory	  WA	25	536	561	
insights	Territory	  WA	137	0	137	
molecular	Territory	  WA	17	42	59	
SP142	Territory	  WA	17	146	163	
pathologist	Territory	  WA	45	211	256	
in-house	Territory	  WA	25	127	152	
22C3	Territory	  WA	49	112	161	
Community TL	Territory	  WA	73	820	893	
sent	Territory	  WA	64	529	593	
utilized	Territory	  WA	45	0	45	
RTL from a major academic institution	Territory	  WI	20	232	252	
community institution	Territory	  WI	31	221	252	
026 Top 300	Territory	  WI	7	245	252	
large community institution	Territory	  WI	13	1371	1384	
NCI	Territory	  WI	16	112	128	
NOT Top 300	Territory	  WI	4	248	252	
academic institution mentioned	Territory	  WI	14	47	61	
single-agent	Territory	  WI	5	0	5	
KEYNOTE-024	Territory	  WI	19	76	95	
CheckMate 227	Territory	  WI	8	8	16	
second-line	Territory	  WI	17	63	80	
eager	Territory	  WI	10	7	17	
first-line	Territory	  WI	26	54	80	
top	Territory	  WI	23	0	23	
major academic institution	Territory	  WI	34	225	259	
RTL mentioned	Territory	  WI	27	0	27	
Checkmate	Territory	  WI	87	792	879	
PD-L1 expression	Territory	  WI	72	703	775	
pembrolizumab	Territory	  WI	65	45	110	
RTL	Territory	  WI	690	801	1491	
Verdict	Territory	  WV	2	5	7	
Phase III	Territory	  WV	23	775	798	
o	Territory	  WV	46	220	266	
NW territory	Territory	  WY	14	1448	1462	
ASCO'16	Territory	  WY	5	394	399	
NeoGenomics	Territory	  WY	8	554	562	
laboratory	Territory	  WY	7	1271	1278	
like to see a trial	Territory	  WY	15	14	29	
Academic TL stated	Territory	  WY	16	162	178	
Ipi+Nivo	Territory	  WY	45	338	383	
medical oncologists	Territory	  WY	23	176	199	
insights	Territory	  WY	137	0	137	
TL said	Territory	  WY	86	62	148	
pathologist	Territory	  WY	45	211	256	
TL	Territory	  WY	1157	51	1208	
PD-L1 testing	Territory	  es	123	444	567	
mRCC	Territory	  for	7	232	239	
uveal	Territory	  n	5	424	429	
years old	Territory	  n	8	0	8	
objective responses	Territory	  n	8	3	11	
BRAF/MEK	Territory	  n	10	362	372	
BRAF	Territory	  n	38	209	247	
regimen	Territory	  n	243	465	708	
Biodesix	Territory	  petitor I	4	34	38	
PR Hem Onc Symposium	Territory	  scape	5	142	147	
atezolizumab	Territory	  t in 2nd	37	3	40	
RAI	Territory	 AL	15	701	716	
context of an online lecture	Territory	 AL	7	659	666	
NAI	Territory	 AL	7	282	289	
NCCN 2016 Webex Congress Series	Territory	 AL	7	657	664	
proactive meeting to discuss CM-026	Territory	 AL	7	257	264	
Bone Marrow Transplant Director	Territory	 AL	5	713	718	
academic institution in the HSL South	Territory	 AL	10	110	120	
Annual New Orleans Summer Cancer	Territory	 AL	4	341	345	
LAI	Territory	 AL	4	238	242	
RAI/NSCLC	Territory	 AL	8	175	183	
made the following comments	Territory	 AL	17	549	566	
South	Territory	 AL	20	360	380	
NCCN panelist for NSCLC	Territory	 AL	11	482	493	
territory	Territory	 AL	35	349	384	
shared the following unsolicited insights	Territory	 AL	26	724	750	
national access influencer	Territory	 AL	7	486	493	
NSCLC NCCN panelist	Territory	 AL	17	665	682	
large academic institution	Territory	 AL	15	478	493	
HSL	Territory	 AL	29	239	268	
CT	Territory	 AL	17	0	17	
ONS	Territory	 AZ	5	198	203	
California	Territory	 AZ	8	290	298	
PD	Territory	 AZ	14	3	17	
surrounding	Territory	 AZ	13	0	13	
tx	Territory	 AZ	24	100	124	
Onc	Territory	 AZ	44	188	232	
NP	Territory	 AZ	31	704	735	
symptoms	Territory	 AZ	28	195	223	
nurse	Territory	 AZ	41	193	234	
release	Territory	 AZ	61	66	127	
pts	Territory	 AZ	164	1624	1788	
mentioned	Territory	 AZ	289	130	419	
bc	Territory	 CENTRAL	11	12	23	
inflamed	Territory	 CENTRAL	5	86	91	
non-inflamed	Territory	 CENTRAL	4	107	111	
phenotype	Territory	 CENTRAL	8	76	84	
Several TLs	Territory	 CENTRAL	11	14	25	
tumor microenvironment	Territory	 CENTRAL	9	84	93	
ll	Territory	 CENTRAL	7	16	23	
single agent Nivo	Territory	 CENTRAL	16	0	16	
deep	Territory	 CENTRAL	11	95	106	
front-line	Territory	 CENTRAL	11	142	153	
T cells	Territory	 CENTRAL	18	46	64	
bladder cancer	Territory	 CENTRAL	23	36	59	
tend	Territory	 CENTRAL	23	0	23	
immune	Territory	 CENTRAL	80	2	82	
RTL stated	Territory	 CENTRAL	93	556	649	
pt	Territory	 CENTRAL	67	23	90	
pts	Territory	 CENTRAL	164	1624	1788	
TLs	Territory	 CENTRAL	98	6	104	
mentioned	Territory	 CENTRAL	289	130	419	
NTL	Territory	 CENTRAL	311	710	1021	
Lung RTL shared	Territory	 CHICAGO	15	59	74	
suit	Territory	 CHICAGO	6	0	6	
Lung NTL	Territory	 CHICAGO	20	669	689	
pts	Territory	 CHICAGO	164	1624	1788	
Lung RTL	Territory	 CHICAGO	71	1103	1174	
added	Territory	 CHICAGO	148	0	148	
shared	Territory	 CHICAGO	507	1	508	
commented	Territory	 CHICAGO	295	327	622	
H&N cancer	Territory	 Chicago	22	39	61	
corticosteroids	Territory	 E. PA	17	260	277	
thought leader	Territory	 E. PA	25	22	47	
National TL	Territory	 E. PA	51	544	595	
competitor	Territory	 E. PA	33	0	33	
PDL-1	Territory	 E. PA	50	881	931	
Regional TL	Territory	 E. PA	100	1088	1188	
major	Territory	 E. PA	90	483	573	
GYN ONC	Territory	 E. TN	4	69	73	
Neuro-ONC	Territory	 E. TN	11	39	50	
National Thought leader	Territory	 E. TN	9	0	9	
respect	Territory	 E. TN	20	122	142	
GBM	Territory	 E. TN	49	79	128	
IO therapy	Territory	 E. TN	64	26	90	
Verdict	Territory	 EASTPA	2	5	7	
Phase III	Territory	 EASTPA	23	775	798	
o	Territory	 EASTPA	46	220	266	
cHL patients	Territory	 East	31	150	181	
bleomycin	Territory	 East	25	100	125	
RTL mentioned	Territory	 East	27	0	27	
TL mentioned	Territory	 East	43	30	73	
post	Territory	 East	69	146	215	
HL	Territory	 East	51	171	222	
cHL	Territory	 East	116	190	306	
q3week	Territory	 FL	7	4	11	
rec/met setting	Territory	 FL	10	408	418	
front	Territory	 FL	52	0	52	
second line	Territory	 FL	78	247	325	
RTL	Territory	 FL	690	801	1491	
tolerance	Territory	 GA	4	0	4	
oncology	Territory	 GA	97	148	245	
practice	Territory	 GA	258	718	976	
NCCN center in the midwest stated	Territory	 IA	12	299	311	
exercise	Territory	 IA	5	238	243	
P&T committee	Territory	 IA	8	478	486	
NCCN center	Territory	 IA	26	280	306	
AI stated	Territory	 IA	24	171	195	
payor	Territory	 IA	7	23	30	
order sets	Territory	 IA	8	321	329	
reactive discussion	Territory	 IA	9	310	319	
advisor	Territory	 IA	27	231	258	
build	Territory	 IA	10	21	31	
midwest	Territory	 IA	42	124	166	
expression levels	Territory	 IA	41	170	211	
unsolicited	Territory	 IA	99	200	299	
perspective	Territory	 IA	25	0	25	
chair	Territory	 IA	26	260	286	
panelist	Territory	 IA	134	164	298	
minimal	Territory	 IA	20	0	20	
o	Territory	 IA	46	220	266	
NCCN panelist	Territory	 IA	94	149	243	
AI	Territory	 IA	121	70	191	
nurse	Territory	 IN	41	193	234	
lots	Territory	 IOCL Lead - HEME	12	0	12	
Colorado	Territory	 IOCL Lead - ST2- North	3	292	295	
Denver	Territory	 IOCL Lead - ST2- North	3	80	83	
suburban	Territory	 IOCL Lead - ST2- North	3	421	424	
breakfast	Territory	 IOCL Lead - ST2- North	3	11	14	
IMAR management	Territory	 IOCL Lead - ST2- North	11	373	384	
provider	Territory	 IOCL Lead - ST2- North	29	0	29	
nurse	Territory	 IOCL Lead - ST2- North	41	193	234	
indicated	Territory	 IOCL Lead - ST2- North	79	459	538	
noted	Territory	 IOCL Lead - ST2- North	144	0	144	
take	Territory	 IOCL Lead - ST2- North	76	0	76	
physicians	Territory	 IOCL Lead - ST2- North	148	339	487	
practice	Territory	 IOCL Lead - ST2- North	258	718	976	
cabozatanib	Territory	 KS	13	190	203	
trx	Territory	 KS	10	0	10	
pace	Territory	 KS	8	208	216	
aPD1	Territory	 KS	7	635	642	
Pan-tumor	Territory	 KS	18	464	482	
ie	Territory	 KS	52	0	52	
modest	Territory	 KS	9	142	151	
2L+	Territory	 KS	12	334	346	
GU RTL stated	Territory	 KS	13	433	446	
Pan	Territory	 KS	10	0	10	
IL-2	Territory	 KS	16	48	64	
not test for PDL1	Territory	 KS	14	651	665	
axitinib	Territory	 KS	14	482	496	
HN	Territory	 KS	21	1	22	
sunitinib	Territory	 KS	19	348	367	
GU	Territory	 KS	84	815	899	
3L	Territory	 KS	19	518	537	
nearly	Territory	 KS	23	0	23	
completely	Territory	 KS	26	3	29	
testing for PDL1	Territory	 KS	39	575	614	
RAI	Territory	 LA	15	701	716	
context of an online lecture	Territory	 LA	7	659	666	
NAI	Territory	 LA	7	282	289	
NCCN 2016 Webex Congress Series	Territory	 LA	7	657	664	
proactive meeting to discuss CM-026	Territory	 LA	7	257	264	
Bone Marrow Transplant Director	Territory	 LA	5	713	718	
academic institution in the HSL South	Territory	 LA	10	110	120	
Annual New Orleans Summer Cancer	Territory	 LA	4	341	345	
LAI	Territory	 LA	4	238	242	
RAI/NSCLC	Territory	 LA	8	175	183	
made the following comments	Territory	 LA	17	549	566	
South	Territory	 LA	20	360	380	
NCCN panelist for NSCLC	Territory	 LA	11	482	493	
Assoc	Territory	 LA	3	312	315	
RCTs	Territory	 LA	3	541	544	
Vice Chancellor Clin Res	Territory	 LA	3	312	315	
territory	Territory	 LA	35	349	384	
shared the following unsolicited insights	Territory	 LA	26	724	750	
national access influencer	Territory	 LA	7	486	493	
NSCLC NCCN panelist	Territory	 LA	17	665	682	
1st line NSCLC	Territory	 MA	17	26	43	
rounds	Territory	 MA	8	5	13	
Boston	Territory	 MA	40	82	122	
3mg/kg	Territory	 MA	17	415	432	
New England	Territory	 MA	17	970	987	
pts	Territory	 MA	164	1624	1788	
inquired	Territory	 MA	29	0	29	
LTL	Territory	 MA	79	800	879	
1st line	Territory	 MA	69	712	781	
added	Territory	 MA	148	0	148	
PD-L1 testing	Territory	 MA	123	444	567	
PD-L1	Territory	 MA	306	375	681	
shared	Territory	 MA	507	1	508	
Northeast	Territory	 ME	9	121	130	
IME	Territory	 ME	3	0	3	
New England	Territory	 ME	17	970	987	
cell carcinoma	Territory	 ME	7	40	47	
NCCN institution	Territory	 ME	16	109	125	
immuno-oncology	Territory	 ME	11	54	65	
produce	Territory	 ME	11	0	11	
US	Territory	 ME	14	24	38	
thought leader	Territory	 ME	25	22	47	
Boston	Territory	 ME	40	82	122	
MD	Territory	 ME	29	71	100	
ipilimumab	Territory	 ME	22	17	39	
renal	Territory	 ME	22	26	48	
cabozantinib	Territory	 ME	27	137	164	
IO agents	Territory	 ME	45	174	219	
major	Territory	 ME	90	483	573	
advanced	Territory	 ME	36	0	36	
hospital	Territory	 ME	72	479	551	
improved	Territory	 ME	36	0	36	
care	Territory	 ME	75	12	87	
NCCN center in the midwest stated	Territory	 MI	12	299	311	
exercise	Territory	 MI	5	238	243	
P&T committee	Territory	 MI	8	478	486	
NCCN center	Territory	 MI	26	280	306	
AI stated	Territory	 MI	24	171	195	
advisor	Territory	 MI	27	231	258	
TL commented	Territory	 MI	83	892	975	
I/O	Territory	 MI	36	184	220	
minimal	Territory	 MI	20	0	20	
midwest	Territory	 MI	42	124	166	
chair	Territory	 MI	26	260	286	
panelist	Territory	 MI	134	164	298	
Local TL	Territory	 MI	52	1414	1466	
H&N	Territory	 MI	117	300	417	
commented	Territory	 MI	295	327	622	
MedOncs	Territory	 MID-ATLANTICMI	4	131	135	
machines	Territory	 MID-ATLANTICMI	3	147	150	
standardized	Territory	 MID-ATLANTICMI	8	132	140	
complementary	Territory	 MID-ATLANTICMI	4	138	142	
SP263	Territory	 MID-ATLANTICMI	8	144	152	
tumor cells	Territory	 MID-ATLANTICMI	22	82	104	
Dako	Territory	 MID-ATLANTICMI	17	124	141	
staining	Territory	 MID-ATLANTICMI	32	620	652	
22C3	Territory	 MID-ATLANTICMI	49	112	161	
aware	Territory	 MID-ATLANTICMI	57	0	57	
PD-L1	Territory	 MID-ATLANTICMI	306	375	681	
large academic	Territory	 MID-ATLANTICSC	78	880	958	
cancer center	Territory	 MID-ATLANTICSC	46	130	176	
large academic center stated	Territory	 MID-WESTIL	25	347	372	
university hospital	Territory	 MID-WESTIL	6	428	434	
midwest	Territory	 MID-WESTIL	42	124	166	
University	Territory	 MID-WESTIL	14	366	380	
RTL at a large academic center	Territory	 MID-WESTIL	22	169	191	
PDL-1	Territory	 MID-WESTIL	50	881	931	
mostly	Territory	 MID-WESTIL	34	0	34	
line	Territory	 MID-WESTIL	345	108	453	
strong	Territory	 MID-WESTIL	50	10	60	
issue	Territory	 MID-WESTIL	87	0	87	
recently	Territory	 MID-WESTIL	93	0	93	
meeting	Territory	 MID-WESTIL	239	35	274	
noted	Territory	 MID-WESTIL	144	0	144	
NTL	Territory	 MID-WESTIL	311	710	1021	
stated	Territory	 MID-WESTIL	860	118	978	
NCCN center in the midwest stated	Territory	 MN	12	299	311	
exercise	Territory	 MN	5	238	243	
P&T committee	Territory	 MN	8	478	486	
NCCN center	Territory	 MN	26	280	306	
AI stated	Territory	 MN	24	171	195	
payor	Territory	 MN	7	23	30	
order sets	Territory	 MN	8	321	329	
reactive discussion	Territory	 MN	9	310	319	
advisor	Territory	 MN	27	231	258	
build	Territory	 MN	10	21	31	
midwest	Territory	 MN	42	124	166	
expression levels	Territory	 MN	41	170	211	
unsolicited	Territory	 MN	99	200	299	
perspective	Territory	 MN	25	0	25	
chair	Territory	 MN	26	260	286	
panelist	Territory	 MN	134	164	298	
minimal	Territory	 MN	20	0	20	
o	Territory	 MN	46	220	266	
NCCN panelist	Territory	 MN	94	149	243	
AI	Territory	 MN	121	70	191	
RAI	Territory	 MS	15	701	716	
context of an online lecture	Territory	 MS	7	659	666	
NAI	Territory	 MS	7	282	289	
NCCN 2016 Webex Congress Series	Territory	 MS	7	657	664	
proactive meeting to discuss CM-026	Territory	 MS	7	257	264	
Bone Marrow Transplant Director	Territory	 MS	5	713	718	
academic institution in the HSL South	Territory	 MS	10	110	120	
Annual New Orleans Summer Cancer	Territory	 MS	4	341	345	
LAI	Territory	 MS	4	238	242	
RAI/NSCLC	Territory	 MS	8	175	183	
made the following comments	Territory	 MS	17	549	566	
South	Territory	 MS	20	360	380	
NCCN panelist for NSCLC	Territory	 MS	11	482	493	
Assoc	Territory	 MS	3	312	315	
RCTs	Territory	 MS	3	541	544	
Vice Chancellor Clin Res	Territory	 MS	3	312	315	
territory	Territory	 MS	35	349	384	
shared the following unsolicited insights	Territory	 MS	26	724	750	
national access influencer	Territory	 MS	7	486	493	
NSCLC NCCN panelist	Territory	 MS	17	665	682	
q3wk	Territory	 N. CA	14	425	439	
myocarditis	Territory	 N. CA	12	62	74	
TLs have stated	Territory	 N. CA	21	203	224	
IO-IO	Territory	 N. CA	21	757	778	
PDL-1	Territory	 N. CA	50	881	931	
TLs	Territory	 N. CA	98	6	104	
provided the following unsolicited insights	Territory	 N.CA	45	146	191	
Met with a national/regional lung	Territory	 N.CA	10	211	221	
Met with a regional	Territory	 N.CA	21	174	195	
AI/TL post-ESMO	Territory	 N.CA	9	660	669	
AI/TL	Territory	 N.CA	27	661	688	
Met with a national	Territory	 N.CA	25	644	669	
genitourinary	Territory	 N.CA	3	757	760	
sensitivity	Territory	 N.CA	3	7	10	
Tony Wang	Territory	 N.CA	3	100	103	
disclosed	Territory	 N.CA	13	182	195	
hit PFS	Territory	 N.CA	6	224	230	
CM 026	Territory	 N.CA	27	207	234	
consideration	Territory	 N.CA	18	0	18	
P&T	Territory	 N.CA	18	182	200	
following unsolicited insights	Territory	 N.CA	79	48	127	
commitment	Territory	 N.CA	6	0	6	
hypothesis	Territory	 N.CA	6	227	233	
KN 024	Territory	 N.CA	17	248	265	
SQ	Territory	 N.CA	8	0	8	
organization	Territory	 N.CA	14	154	168	
RTL from a major academic institution	Territory	 ND	20	232	252	
community institution	Territory	 ND	31	221	252	
NCCN center in the midwest stated	Territory	 ND	12	299	311	
026 Top 300	Territory	 ND	7	245	252	
large community institution	Territory	 ND	13	1371	1384	
exercise	Territory	 ND	5	238	243	
academic institution mentioned	Territory	 ND	14	47	61	
P&T committee	Territory	 ND	8	478	486	
KEYNOTE-024	Territory	 ND	19	76	95	
NCCN center	Territory	 ND	26	280	306	
AI stated	Territory	 ND	24	171	195	
CheckMate 227	Territory	 ND	8	8	16	
second-line	Territory	 ND	17	63	80	
first-line	Territory	 ND	26	54	80	
major academic institution	Territory	 ND	34	225	259	
advisor	Territory	 ND	27	231	258	
expression levels	Territory	 ND	41	170	211	
poster	Territory	 ND	23	284	307	
midwest	Territory	 ND	42	124	166	
perspective	Territory	 ND	25	0	25	
Northeast	Territory	 NEW ENGLANDMA	9	121	130	
IME	Territory	 NEW ENGLANDMA	3	0	3	
New England	Territory	 NEW ENGLANDMA	17	970	987	
cell carcinoma	Territory	 NEW ENGLANDMA	7	40	47	
NCCN institution	Territory	 NEW ENGLANDMA	16	109	125	
immuno-oncology	Territory	 NEW ENGLANDMA	11	54	65	
produce	Territory	 NEW ENGLANDMA	11	0	11	
US	Territory	 NEW ENGLANDMA	14	24	38	
thought leader	Territory	 NEW ENGLANDMA	25	22	47	
Boston	Territory	 NEW ENGLANDMA	40	82	122	
MD	Territory	 NEW ENGLANDMA	29	71	100	
ipilimumab	Territory	 NEW ENGLANDMA	22	17	39	
renal	Territory	 NEW ENGLANDMA	22	26	48	
cabozantinib	Territory	 NEW ENGLANDMA	27	137	164	
IO agents	Territory	 NEW ENGLANDMA	45	174	219	
major	Territory	 NEW ENGLANDMA	90	483	573	
advanced	Territory	 NEW ENGLANDMA	36	0	36	
hospital	Territory	 NEW ENGLANDMA	72	479	551	
improved	Territory	 NEW ENGLANDMA	36	0	36	
care	Territory	 NEW ENGLANDMA	75	12	87	
NTL in the Boston area mentioned	Territory	 NEW ENGLANDN.NY	9	137	146	
Boston area	Territory	 NEW ENGLANDN.NY	19	27	46	
RTL at a large academic center	Territory	 NEW ENGLANDN.NY	22	169	191	
bleo	Territory	 NEW ENGLANDN.NY	17	114	131	
Boston	Territory	 NEW ENGLANDN.NY	40	82	122	
BV	Territory	 NEW ENGLANDN.NY	33	158	191	
stop	Territory	 NEW ENGLANDN.NY	67	137	204	
mentioned	Territory	 NEW ENGLANDN.NY	289	130	419	
Northeast	Territory	 NH	9	121	130	
IME	Territory	 NH	3	0	3	
New England	Territory	 NH	17	970	987	
cell carcinoma	Territory	 NH	7	40	47	
NCCN institution	Territory	 NH	16	109	125	
immuno-oncology	Territory	 NH	11	54	65	
produce	Territory	 NH	11	0	11	
US	Territory	 NH	14	24	38	
thought leader	Territory	 NH	25	22	47	
Boston	Territory	 NH	40	82	122	
MD	Territory	 NH	29	71	100	
ipilimumab	Territory	 NH	22	17	39	
renal	Territory	 NH	22	26	48	
cabozantinib	Territory	 NH	27	137	164	
IO agents	Territory	 NH	45	174	219	
major	Territory	 NH	90	483	573	
advanced	Territory	 NH	36	0	36	
hospital	Territory	 NH	72	479	551	
improved	Territory	 NH	36	0	36	
care	Territory	 NH	75	12	87	
NCI	Territory	 NORTH CENTRALIA	16	112	128	
hematologic malignancies	Territory	 NORTH CENTRALIA	5	4	9	
PET	Territory	 NORTH CENTRALIA	11	0	11	
cancer center	Territory	 NORTH CENTRALIA	46	130	176	
lymphoma	Territory	 NORTH CENTRALIA	73	12	85	
academic center	Territory	 NORTH CENTRALIA	103	319	422	
noted	Territory	 NORTH CENTRALIA	144	0	144	
NCCN center in the midwest stated	Territory	 NORTH CENTRALWI	12	299	311	
exercise	Territory	 NORTH CENTRALWI	5	238	243	
P&T committee	Territory	 NORTH CENTRALWI	8	478	486	
NCCN center	Territory	 NORTH CENTRALWI	26	280	306	
AI stated	Territory	 NORTH CENTRALWI	24	171	195	
payor	Territory	 NORTH CENTRALWI	7	23	30	
order sets	Territory	 NORTH CENTRALWI	8	321	329	
reactive discussion	Territory	 NORTH CENTRALWI	9	310	319	
advisor	Territory	 NORTH CENTRALWI	27	231	258	
build	Territory	 NORTH CENTRALWI	10	21	31	
midwest	Territory	 NORTH CENTRALWI	42	124	166	
expression levels	Territory	 NORTH CENTRALWI	41	170	211	
unsolicited	Territory	 NORTH CENTRALWI	99	200	299	
perspective	Territory	 NORTH CENTRALWI	25	0	25	
chair	Territory	 NORTH CENTRALWI	26	260	286	
panelist	Territory	 NORTH CENTRALWI	134	164	298	
minimal	Territory	 NORTH CENTRALWI	20	0	20	
o	Territory	 NORTH CENTRALWI	46	220	266	
NCCN panelist	Territory	 NORTH CENTRALWI	94	149	243	
AI	Territory	 NORTH CENTRALWI	121	70	191	
Path TL	Territory	 NORTHEASTNY	18	230	248	
Path	Territory	 NORTHEASTNY	19	0	19	
LDT	Territory	 NORTHEASTNY	4	22	26	
IVD	Territory	 NORTHEASTNY	6	146	152	
score	Territory	 NORTHEASTNY	21	156	177	
pathologist	Territory	 NORTHEASTNY	45	211	256	
22C3	Territory	 NORTHEASTNY	49	112	161	
reported	Territory	 NORTHEASTNY	182	10	192	
TL stated	Territory	 NORTHEASTNY	202	488	690	
TL	Territory	 NORTHEASTNY	1157	51	1208	
southeast region	Territory	 NORTHEASTNYC	7	169	176	
gathered the following unsolicited	Territory	 NORTHEASTNYC	6	175	181	
Ritchie	Territory	 NORTHEASTNYC	6	170	176	
NCI-designated	Territory	 NORTHEASTNYC	8	157	165	
Joseph	Territory	 NORTHEASTNYC	7	170	177	
junior	Territory	 NORTHEASTNYC	4	394	398	
faculty	Territory	 NORTHEASTNYC	4	394	398	
yield	Territory	 NORTHEASTNYC	5	0	5	
evolving	Territory	 NORTHEASTNYC	10	77	87	
comparable	Territory	 NORTHEASTNYC	13	498	511	
wasn	Territory	 NORTHEASTNYC	8	109	117	
symposium	Territory	 NORTHEASTNYC	26	152	178	
NTLs	Territory	 NORTHEASTNYC	13	120	133	
thoracic	Territory	 NORTHEASTNYC	10	142	152	
position	Territory	 NORTHEASTNYC	14	383	397	
landscape	Territory	 NORTHEASTNYC	40	0	40	
doesn	Territory	 NORTHEASTNYC	36	94	130	
volunteered	Territory	 NORTHEASTNYC	28	243	271	
CM-026	Territory	 NORTHEASTNYC	52	177	229	
member	Territory	 NORTHEASTNYC	37	111	148	
cHD	Territory	 NORTHEASTNYC-NY	6	318	324	
bar	Territory	 NORTHEASTNYC-NY	13	0	13	
Community TL	Territory	 NORTHWESTAK	73	820	893	
utilized	Territory	 NORTHWESTAK	45	0	45	
offered	Territory	 NORTHWESTAK	88	0	88	
HL	Territory	 NORTHWESTAK	51	171	222	
NW territory	Territory	 NORTHWESTCO	14	1448	1462	
sky-rocketed	Territory	 NORTHWESTCO	3	577	580	
NeoGenomics	Territory	 NORTHWESTCO	8	554	562	
laboratory	Territory	 NORTHWESTCO	7	1271	1278	
clone	Territory	 NORTHWESTCO	5	149	154	
diagnostics	Territory	 NORTHWESTCO	8	1288	1296	
medical director	Territory	 NORTHWESTCO	8	365	373	
healthcare	Territory	 NORTHWESTCO	6	688	694	
Ventana platform	Territory	 NORTHWESTCO	7	145	152	
reflex testing	Territory	 NORTHWESTCO	11	91	102	
medical oncologists	Territory	 NORTHWESTCO	23	176	199	
platform	Territory	 NORTHWESTCO	18	149	167	
IHC	Territory	 NORTHWESTCO	25	536	561	
insights	Territory	 NORTHWESTCO	137	0	137	
molecular	Territory	 NORTHWESTCO	17	42	59	
SP142	Territory	 NORTHWESTCO	17	146	163	
pathologist	Territory	 NORTHWESTCO	45	211	256	
network	Territory	 NORTHWESTCO	18	441	459	
pathology	Territory	 NORTHWESTCO	19	213	232	
gained	Territory	 NORTHWESTCO	19	86	105	
provided the following unsolicited insights	Territory	 NORTHWESTOR	45	146	191	
Met with a national/regional lung	Territory	 NORTHWESTOR	10	211	221	
Met with a regional	Territory	 NORTHWESTOR	21	174	195	
AI/TL post-ESMO	Territory	 NORTHWESTOR	9	660	669	
AI/TL	Territory	 NORTHWESTOR	27	661	688	
Met with a national	Territory	 NORTHWESTOR	25	644	669	
genitourinary	Territory	 NORTHWESTOR	3	757	760	
sensitivity	Territory	 NORTHWESTOR	3	7	10	
Tony Wang	Territory	 NORTHWESTOR	3	100	103	
disclosed	Territory	 NORTHWESTOR	13	182	195	
hit PFS	Territory	 NORTHWESTOR	6	224	230	
CM 026	Territory	 NORTHWESTOR	27	207	234	
consideration	Territory	 NORTHWESTOR	18	0	18	
P&T	Territory	 NORTHWESTOR	18	182	200	
following unsolicited insights	Territory	 NORTHWESTOR	79	48	127	
commitment	Territory	 NORTHWESTOR	6	0	6	
hypothesis	Territory	 NORTHWESTOR	6	227	233	
KN 024	Territory	 NORTHWESTOR	17	248	265	
SQ	Territory	 NORTHWESTOR	8	0	8	
organization	Territory	 NORTHWESTOR	14	154	168	
international GI conference	Territory	 NYC - ST2	17	43	60	
said	Territory	 NYC - ST2	479	0	479	
international GI conference	Territory	 NYC -ST2	17	43	60	
pancreatic cancer	Territory	 NYC -ST2	9	57	66	
NY	Territory	 New York City - ST1	13	194	207	
told	Territory	 New York City - ST1	136	65	201	
affiliation	Territory	 No longer with FM	3	467	470	
voluntarily	Territory	 OK	7	0	7	
I-O agents	Territory	 OK	14	6	20	
H&N cancer	Territory	 OK	22	39	61	
CM-026	Territory	 OK	52	177	229	
TL shared	Territory	 OK	119	1081	1200	
feels	Territory	 OK	397	56	453	
lung TL said	Territory	 PA	16	1110	1126	
atezi	Territory	 PA	5	27	32	
Regional lung TL told	Territory	 PA	21	2	23	
Fall ECOG	Territory	 PA	4	148	152	
voiced his opinion	Territory	 PA	7	16	23	
Local lung TL commented	Territory	 PA	14	0	14	
isn	Territory	 PA	11	106	117	
GR	Territory	 PA	5	0	5	
second	Territory	 PA	5	0	5	
H&N TL	Territory	 PA	20	432	452	
sutent	Territory	 PA	8	3	11	
TL told	Territory	 PA	65	938	1003	
Local	Territory	 PA	184	1056	1240	
t	Territory	 PA	117	0	117	
doesn	Territory	 PA	36	94	130	
TL said	Territory	 PA	86	62	148	
said	Territory	 PA	479	0	479	
line	Territory	 PA	345	108	453	
told	Territory	 PA	136	65	201	
national	Territory	 PA	183	979	1162	
HCP	Territory	 Puerto Rico	115	124	239	
consultant	Territory	 Puerto Rico MSL	5	207	212	
Post-ASCO	Territory	 Puerto Rico MSL	6	418	424	
Northeast	Territory	 RI	9	121	130	
IME	Territory	 RI	3	0	3	
New England	Territory	 RI	17	970	987	
cell carcinoma	Territory	 RI	7	40	47	
NCCN institution	Territory	 RI	16	109	125	
immuno-oncology	Territory	 RI	11	54	65	
produce	Territory	 RI	11	0	11	
US	Territory	 RI	14	24	38	
thought leader	Territory	 RI	25	22	47	
Boston	Territory	 RI	40	82	122	
MD	Territory	 RI	29	71	100	
ipilimumab	Territory	 RI	22	17	39	
renal	Territory	 RI	22	26	48	
cabozantinib	Territory	 RI	27	137	164	
IO agents	Territory	 RI	45	174	219	
major	Territory	 RI	90	483	573	
advanced	Territory	 RI	36	0	36	
hospital	Territory	 RI	72	479	551	
improved	Territory	 RI	36	0	36	
care	Territory	 RI	75	12	87	
CLL	Territory	 ROCKY MOUNTAINUT	5	98	103	
like to see a trial	Territory	 ROCKY MOUNTAINUT	15	14	29	
GVHD	Territory	 ROCKY MOUNTAINUT	21	118	139	
high-grade	Territory	 S. CA	5	192	197	
NTL in GU	Territory	 S. CA	9	499	508	
NTL said	Territory	 S. CA	24	14	38	
Academic NTL	Territory	 S. CA	11	12	23	
RTL said	Territory	 S. CA	31	0	31	
anti-PD-1	Territory	 S. CA	31	661	692	
KN-024 and CM-026	Territory	 S. CA	15	310	325	
cited	Territory	 S. CA	33	0	33	
first-line	Territory	 S. CA	26	54	80	
guide	Territory	 S. CA	28	116	144	
shared	Territory	 S. CA	507	1	508	
feels	Territory	 S. CA	397	56	453	
NCCN center in the midwest stated	Territory	 SD	12	299	311	
exercise	Territory	 SD	5	238	243	
P&T committee	Territory	 SD	8	478	486	
NCCN center	Territory	 SD	26	280	306	
AI stated	Territory	 SD	24	171	195	
payor	Territory	 SD	7	23	30	
order sets	Territory	 SD	8	321	329	
reactive discussion	Territory	 SD	9	310	319	
advisor	Territory	 SD	27	231	258	
build	Territory	 SD	10	21	31	
midwest	Territory	 SD	42	124	166	
expression levels	Territory	 SD	41	170	211	
unsolicited	Territory	 SD	99	200	299	
perspective	Territory	 SD	25	0	25	
chair	Territory	 SD	26	260	286	
panelist	Territory	 SD	134	164	298	
minimal	Territory	 SD	20	0	20	
o	Territory	 SD	46	220	266	
NCCN panelist	Territory	 SD	94	149	243	
AI	Territory	 SD	121	70	191	
RAI	Territory	 SOUTHAK	15	701	716	
context of an online lecture	Territory	 SOUTHAK	7	659	666	
NAI	Territory	 SOUTHAK	7	282	289	
NCCN 2016 Webex Congress Series	Territory	 SOUTHAK	7	657	664	
proactive meeting to discuss CM-026	Territory	 SOUTHAK	7	257	264	
Bone Marrow Transplant Director	Territory	 SOUTHAK	5	713	718	
academic institution in the HSL South	Territory	 SOUTHAK	10	110	120	
Annual New Orleans Summer Cancer	Territory	 SOUTHAK	4	341	345	
LAI	Territory	 SOUTHAK	4	238	242	
RAI/NSCLC	Territory	 SOUTHAK	8	175	183	
made the following comments	Territory	 SOUTHAK	17	549	566	
South	Territory	 SOUTHAK	20	360	380	
NCCN panelist for NSCLC	Territory	 SOUTHAK	11	482	493	
Assoc	Territory	 SOUTHAK	3	312	315	
RCTs	Territory	 SOUTHAK	3	541	544	
Vice Chancellor Clin Res	Territory	 SOUTHAK	3	312	315	
territory	Territory	 SOUTHAK	35	349	384	
shared the following unsolicited insights	Territory	 SOUTHAK	26	724	750	
national access influencer	Territory	 SOUTHAK	7	486	493	
NSCLC NCCN panelist	Territory	 SOUTHAK	17	665	682	
Pediatric Oncology/ Hematology	Territory	 SOUTHTN	4	319	323	
Pediatric	Territory	 SOUTHTN	11	367	378	
Brentuximab vedotin	Territory	 SOUTHTN	11	135	146	
ASCT	Territory	 SOUTHTN	10	190	200	
academic center	Territory	 SOUTHTN	103	319	422	
described	Territory	 SOUTHTN	44	0	44	
brentuximab	Territory	 SOUTHTN	36	163	199	
lymphoma	Territory	 SOUTHTN	73	12	85	
transplant	Territory	 SOUTHTN	92	193	285	
cHL	Territory	 SOUTHTN	116	190	306	
large	Territory	 SOUTHTN	283	242	525	
nivolumab	Territory	 SOUTHTN	335	5	340	
NTL	Territory	 SOUTHTN	311	710	1021	
auto	Territory	 SOUTHEASTGA	15	204	219	
pt	Territory	 SOUTHEASTGA	67	23	90	
reported	Territory	 SOUTHEASTGA	182	10	192	
like to see a trial	Territory	 SOUTHWESTS.CA	15	14	29	
BMS-sponsored	Territory	 TEXASTX	2	50	52	
novel	Territory	 TEXASTX	10	9	19	
RAI	Territory	 TN	15	701	716	
context of an online lecture	Territory	 TN	7	659	666	
NAI	Territory	 TN	7	282	289	
NCCN 2016 Webex Congress Series	Territory	 TN	7	657	664	
proactive meeting to discuss CM-026	Territory	 TN	7	257	264	
Bone Marrow Transplant Director	Territory	 TN	5	713	718	
academic institution in the HSL South	Territory	 TN	10	110	120	
Annual New Orleans Summer Cancer	Territory	 TN	4	341	345	
LAI	Territory	 TN	4	238	242	
RAI/NSCLC	Territory	 TN	8	175	183	
made the following comments	Territory	 TN	17	549	566	
South	Territory	 TN	20	360	380	
NCCN panelist for NSCLC	Territory	 TN	11	482	493	
Assoc	Territory	 TN	3	312	315	
RCTs	Territory	 TN	3	541	544	
Vice Chancellor Clin Res	Territory	 TN	3	312	315	
territory	Territory	 TN	35	349	384	
shared the following unsolicited insights	Territory	 TN	26	724	750	
national access influencer	Territory	 TN	7	486	493	
NSCLC NCCN panelist	Territory	 TN	17	665	682	
Numerous TLs	Territory	 UT	6	253	259	
tone	Territory	 UT	4	0	4	
restriction	Territory	 UT	6	16	22	
AE profile	Territory	 UT	14	338	352	
comers	Territory	 UT	20	0	20	
q3wk	Territory	 UT	14	425	439	
TLs	Territory	 UT	98	6	104	
established	Territory	 UT	17	0	17	
IO-IO	Territory	 UT	21	757	778	
highly	Territory	 UT	30	34	64	
key	Territory	 UT	37	0	37	
PDL1 status	Territory	 UT	39	874	913	
SOC	Territory	 UT	69	492	561	
specifically	Territory	 UT	50	48	98	
increase	Territory	 UT	113	36	149	
regards	Territory	 UT	112	0	112	
population	Territory	 UT	222	248	470	
IO	Territory	 UT	242	52	294	
1L	Territory	 UT	288	292	580	
no PD-L1 testing	Territory	 VA&P Sales	5	36	41	
IDN	Territory	 VA&P Sales	8	100	108	
customer	Territory	 VA&P Sales	14	0	14	
medical policy	Territory	 VA&P Sales	10	161	171	
health	Territory	 VA&P Sales	25	0	25	
pharmacy	Territory	 VA&P Sales	29	48	77	
HEOR	Territory	 VA&P Sales	16	20	36	
contract	Territory	 VA&P Sales	12	83	95	
class	Territory	 VA&P Sales	21	0	21	
product	Territory	 VA&P Sales	37	20	57	
oncology	Territory	 VA&P Sales	97	148	245	
clinical	Territory	 VA&P Sales	213	0	213	
Opdivo	Territory	 VA&P Sales	445	28	473	
Northeast	Territory	 VT	9	121	130	
IME	Territory	 VT	3	0	3	
New England	Territory	 VT	17	970	987	
cell carcinoma	Territory	 VT	7	40	47	
NCCN institution	Territory	 VT	16	109	125	
immuno-oncology	Territory	 VT	11	54	65	
produce	Territory	 VT	11	0	11	
US	Territory	 VT	14	24	38	
thought leader	Territory	 VT	25	22	47	
Boston	Territory	 VT	40	82	122	
MD	Territory	 VT	29	71	100	
ipilimumab	Territory	 VT	22	17	39	
renal	Territory	 VT	22	26	48	
cabozantinib	Territory	 VT	27	137	164	
IO agents	Territory	 VT	45	174	219	
major	Territory	 VT	90	483	573	
advanced	Territory	 VT	36	0	36	
hospital	Territory	 VT	72	479	551	
improved	Territory	 VT	36	0	36	
care	Territory	 VT	75	12	87	
:regional TL shared	Territory	 W. TN	18	18	36	
TL told	Territory	 W. TN	65	938	1003	
anti-PD1	Territory	 W. TN	38	55	93	
TL shared	Territory	 W. TN	119	1081	1200	
offered	Territory	 W. TN	88	0	88	
commented	Territory	 W. TN	295	327	622	
provided the following unsolicited insights	Territory	 WA	45	146	191	
Met with a national/regional lung	Territory	 WA	10	211	221	
Met with a regional	Territory	 WA	21	174	195	
AI/TL post-ESMO	Territory	 WA	9	660	669	
AI/TL	Territory	 WA	27	661	688	
ASCO'16	Territory	 WA	5	394	399	
Met with a national	Territory	 WA	25	644	669	
FDA blueprint	Territory	 WA	6	57	63	
disclosed	Territory	 WA	13	182	195	
hit PFS	Territory	 WA	6	224	230	
CM 026	Territory	 WA	27	207	234	
distinction	Territory	 WA	5	14	19	
consideration	Territory	 WA	18	0	18	
P&T	Territory	 WA	18	182	200	
following unsolicited insights	Territory	 WA	79	48	127	
KN 024	Territory	 WA	17	248	265	
SQ	Territory	 WA	8	0	8	
organization	Territory	 WA	14	154	168	
AI	Territory	 WA	121	70	191	
reactively	Territory	 WA	41	170	211	
cytology	Territory	 WESTAZ	4	159	163	
volume	Territory	 WESTAZ	31	9	40	
in-house	Territory	 WESTAZ	25	127	152	
score	Territory	 WESTAZ	21	156	177	
requests	Territory	 WESTAZ	61	545	606	
